Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

Epidemiological surveys in humans show that smokers tend to smoke more cigarettes while drinking coffee, and they also drink significantly more coffee than nonsmokers (Istvan and Matarazzo, 1984; Brown and Benowitz, 1989; Swanson et al., 1994, 1997). It is now generally accepted that this positive correlation can be ascribed to interactions between nicotine and caffeine, the main psychoactive constituents of tobacco and coffee, respectively (Rose and Behm, 1991; Swanson et al., 1994, 1997; Griffiths and Mumford, 1995). Little is known, however, of the neuropharmacological and psychopharmacological mechanisms or of their behavioral consequences that may contribute to the concurrent use of nicotine and caffeine in humans. Pharmacokinetic factors such as a shorter half-life of caffeine or nicotine in coffee-drinking smokers or behavioral factors such as stress or anxiety can only partially explain their concurrent use (Brown and Benowitz, 1989; Swanson et al., 1994, 1997), suggesting that other factors are involved (Istvan and Matarazzo, 1984).

Both nicotine and caffeine, when administered alone, can have qualitatively comparable, often biphasic, dose-dependent effects on a variety of nonoperant and operant measures of behavior (for review, see Carney et al., 1985; Stolerman, 1990; Nehlig et al., 1992). These behavioral effects include, for example, increases in locomotor activity (Holtzman, 1983; Lee et al., 1987; Nikodijevic et al., 1993) and rates of schedule-controlled responding (White, 1988; Goldberg et al., 1989; Newland and Brown, 1997; Jaszyna et al., 1998) followed by decreases as doses of the drugs increase. Moreover, both nicotine and caffeine can each serve as discriminative stimuli (Winter, 1981; Stolerman et al., 1984; Carney et al., 1985; Rosecrans, 1989; Griffiths et al., 1990) and reinforcing stimuli under certain conditions (Goldberg and Henningfield, 1988; Heishman and Henningfield, 1992; Griffiths and Mumford, 1995; Rose and Corrigall, 1997) in laboratory animals and human subjects. Nicotine and caffeine, when coadministered acutely, have been shown to produce additive-in-nature stimulation of locomotor activity and increases in rates of operant responding maintained under a fixed-interval schedule of food reinforcement in rats (Lee et al., 1987; White, 1988) and monkeys (Howell and Landrum, 1997). Acute pretreatment with caffeine also produced significant increases in rates of responding for i.v. nicotine self-administration in squirrel monkeys (Yasar et al., 1997). Caffeine, however, is consumed chronically by humans, and behavioral responses to caffeine can be altered by repeated administration (see review by Jacobson et al., 1996), as observed with other psychomotor stimulant drugs (Goudie and Emmett-Oglesby, 1989; Stewart and Badiani, 1993), suggesting the need for more studies of the effects of chronic caffeine exposure on nicotine's behavioral actions.

It has been well documented that daily exposure to "physiological" doses of caffeine (equivalent to the caffeine content in two to three cups of coffee) results in the development of tolerance to the diuretic, cardiovascular, and some, but not all, of the behavioral effects of caffeine in humans (Benowitz, 1990; James, 1991; Nehlig et al., 1992). Likewise, chronic caffeine exposure in rodents results in the development of tolerance to the stimulant effects of caffeine on locomotor activity and rates of food-reinforced responding, and its effects as a discriminative stimulus (Holtzman and Finn, 1988; Nikodijevic et al., 1993; Lau and Falk, 1994; Newland and Brown, 1997; Jaszyna et al., 1998). There is no clear predictive pattern of change in the behavioral effects of psychomotor-stimulant drugs that are produced by chronic caffeine exposure in experimental animals. For example, chronic caffeine exposure markedly potentiated the stimulatory effects of nicotine on locomotor activity (Shoaib et al., 1996), whereas the response to amphetamine and cocaine remained unchanged (Holtzman, 1983; Finn and Holtzman, 1987; Holtzman and Finn, 1988; Nikodijevic et al., 1993). In contrast, chronic caffeine exposure potentiated the response-rate increases produced by amphetamine and cocaine, but not by nicotine, in rats responding under a fixed interval (FI) schedule of food reinforcement (Jaszyna et al., 1998). Chronic caffeine exposure, however, increased rates of acquisition of i.v. self-administration of both nicotine (Shoaib et al., 1996) and cocaine (Horger et al., 1991) relative to control rats.

To our knowledge there are no published reports on how chronic caffeine exposure might change the discriminative stimulus properties of psychomotor stimulant drugs. There is some experimental evidence suggesting that acute presession treatment with caffeine can potentiate the discriminative stimulus effects of cocaine in rats (Harland et al., 1989; Gauvin et al., 1990), and combinations of caffeine with other over-the-counter drugs such as phenylethylamine can produce new entities distinct from their component elements and can mimic the discriminative cue of amphetamine and cocaine (Holloway et al., 1985; Gauvin et al., 1989). Thus, there are reasons to speculate that chronic caffeine exposure may change the subjective effects of psychomotor stimulants, including nicotine.

In the present study, we adopted from Holtzman (1983) and Jaszyna et al. (1998) a method of chronically exposing rats to caffeine in their drinking water to examine possible changes in the subjective effects of nicotine using a drug discrimination procedure. Drug discrimination procedures have been successfully used to examine subjective effects of a wide range of psychoactive drugs under a variety of experimental conditions in both animals (e.g., Colpaert, 1987; Samele et al., 1992) and humans (e.g., Kamien et al., 1993). With these procedures, discriminability of a drug (percentage of subjects acquiring discrimination) and rate of acquisition of the discrimination are first established and then qualitative properties of the discriminative cue are assessed in generalization tests with other drugs permitting identification of receptor(s) mediating discriminative-stimulus properties of the drug (e.g., Colpaert, 1987; Wiley et al., 1996). All three characteristics of the discriminative effects of nicotine in rats chronically exposed to caffeine, in comparison to those of in control rats, were evaluated in the present study.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

Subjects. Thirty experimentally naive, male Sprague-Dawley rats, weighing 250 to 280 g at the beginning of the study, were used. Rats were acclimated to laboratory conditions and allowed to free feed for 2 weeks. Their body weights were then reduced to about 80% of free-feeding by limiting access to food. Rats continued to be kept on a restricted diet to maintain their weights at about 80 ± 5.0% of the weight of age-matched control rats until the end of the study. Rats were housed individually in stainless steel cages in a temperature- and humidity-controlled room with a 12-h light/dark cycle (7:00-19:00 h lights on).

Drugs. The drugs and their sources were as follows: ()-nicotine hydrogen tartrate (Sigma Chemical Company, St. Louis, MO), caffeine base (Sigma), mecamylamine HCl (Research Biochemicals International, RBI, Natick, MA), CGS 10746B (5-(4-methyl-1-piperazinyl)imidazo[2,1-b][1,3,5]-benzothiadiazepine maleate; a gift from Novartis Pharmaceutical Corp., Summit, NJ), d-amphetamine (National Institute on Drug Abuse, Rockville, MD), cocaine HCl (National Institute on Drug Abuse), GBR-12909 2·HCl (1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-[3-phenylpropyl]piperazine dichloride; RBI), R()-apomorphine HCL (R()-10,11-dihydroxyapomorphine hydrochloride; RBI), (±)-SKF-82958 HBr ((±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide; RBI), R()-NPA HCl (R()-10,11-dihydroxy-N-n-propylnoraporphine hydrochloride; RBI), S(+)-PD 128,907 HCl (S(+)-(4aR,10bR)-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano-[4,3-b]-1,4-oxazin-9-ol hydrochloride; RBI). GBR-12909 was suspended in 40% (w/v) hydroxypropyl--cyclodextrin (RBI), CGS 10746B was dissolved in sterile water, and the remaining drugs were dissolved in sterile 0.9% NaCl saline. The pH of nicotine solutions was adjusted to 7.0 with dilute NaOH. When necessary, mild heat and sonication were applied to prepare solutions of the drugs. Except for nicotine and caffeine, doses of drugs are expressed as milligrams of salt per kilogram of body weight measured before the start of the session. Doses of nicotine and caffeine refer to the free base forms. The drugs were administered either s.c. (nicotine and mecamylamine) or i.p. (the remaining drugs) in a volume of 1.0 ml/kg of body weight.

Apparatus. Standard operant chambers (Coulbourn Instruments Inc., Lehigh Valley, PA) located singly in sound-attenuating plastic cubicles were used. Each chamber contained two levers separated by a recessed tray into which a pellet dispenser could deliver 45-mg food pellets (Bio-Serv, Inc., Frenchtown, NJ), a house light that was centrally mounted on the front wall below the ceiling, and a device producing white noise to mask extraneous sounds. Each press of a lever with a force of 0.4 N through 1 mm was recorded as a response and was accompanied by an audible click. The chamber was controlled by a computer using MED-PC software (Med Associates, Inc., East Fairfield, VT).

Training Procedure. Twenty-four rats were trained to press the lever for food on a fixed ratio (FR) schedule of reinforcement 5 days a week (Monday through Friday), always between 9:30 AM and 12:00 PM. At the start of each session, the white house light was turned on and in its presence 10 consecutive responses on the active lever delivered a food pellet (a fixed-ratio 10 schedule; FR 10) and initiated a 3-s timeout during which lever presses had no programmed consequences and the chamber was dark. After each timeout, the house light was turned on and food was again available. Each session lasted 15 min. The location of the active lever (left versus right) was randomly changed for each session to reduce position preferences during the training period. Once all rats responded reliably under the FR 10 schedule, they were divided into two groups: water-drinking rats and caffeine-drinking rats. Twelve animals received free access in their home cages to caffeine in tap water (3 mg/ml caffeine anhydrate base), whereas the other 12 control rats continued to drink tap water. Daily caffeine intake was estimated once every week throughout the remainder of the study based on the rat's body weight and 24-h fluid consumption of the established caffeine concentration (mg/kg per individual rat). Daily water intake in water-drinking rats was monitored for comparison. Training was continued for 2 weeks to eliminate temporal effects of caffeine on behavior in rats.

Acquisition of Nicotine Discrimination. Water- and caffeine-drinking rats were then divided into four groups of six rats each and trained, as described previously (Shoaib and Stolerman, 1996), under the FR10 schedule of food delivery to respond on one lever after s.c. injection of nicotine and on the other lever after s.c. injection of an equivalent volume of saline vehicle. Two groups of rats (water- and caffeine-drinking) were trained to discriminate 0.1 mg/kg of nicotine from saline and two groups of rats (water- and caffeine-drinking) were trained to discriminate 0.4 mg/kg of nicotine from saline. For half the rats in each group, the right lever was the drug lever and for the other half, the left lever was the drug lever. This remained constant throughout the study. Injections of nicotine or saline were given s.c. 10 min before the session.

Tests for Generalization or Antagonism. Test sessions were identical to training sessions with the exception that 10 responses on either lever resulted in delivery of a food pellet. There were no more than two test sessions conducted per week (usually on Tuesdays and Fridays) and there were regular training sessions with either nicotine or saline injections conducted on the other days to ensure robust stimulus control. Only rats that continued to meet the above criteria for stimulus control were tested. If a rat failed to meet criteria for stimulus control during one of the training sessions, it remained in the training condition until at least five consecutive sessions were completed in which criteria were met.

Sequence of Testing. The following parameters, in order of their assessment, were compared in water- and caffeine-drinking rats: 1) rates of acquisition of the nicotine discrimination, 2) discrimination of different doses of nicotine (0.025-0.8 mg/kg; 10 min before test session) to establish dose-response functions, 3) ability of the nicotinic-receptor antagonist, mecamylamine (0.01-1.0 mg/kg; 20 min before test sessions), to block the discriminative stimulus actions of nicotine, and 4) abilities of a variety of drugs that act at different receptors to generalize to the nicotine-discriminative stimulus. The drugs studied (doses and pretreatment times in parentheses) were: caffeine (1.0-56 mg/kg; 15 min), d-amphetamine (0.3-3.0 mg/kg; 10 min), cocaine (0.3-17 mg/kg; 10 min), the selective dopamine-uptake inhibitor GBR-12909 (3.0-17 mg/kg; 15 min), the nonselective dopamine agonist apomorphine (0.1-0.3 mg/kg; 10 min), the selective D1, D2, and D3 dopamine-receptor agonists, SKF-82958 (0.01-0.17 mg/kg; 10 min), NPA (0.001-0.01 mg/kg; 10 min), and PD 128,907 (0.03-0.3 mg/kg; 15 min), respectively, and 5) ability of the dopamine-release inhibitor, CGS 10746B (3.0-30 mg/kg; 30 min before test sessions), to block the discriminative-stimulus actions of nicotine. Dose-response functions for nicotine were redetermined after the above tests to assess whether any tolerance or sensitivity to nicotine had developed over time or as a result of different treatments. Finally, the ability of amphetamine (0.3-3.0 mg/kg; 10 min) to generalize to the nicotine discriminative stimulus was assessed in rats subjected to a double crossover design in which caffeine was either removed or added to the drinking water of caffeine- and water-drinking rats, respectively.

Measurement of Plasma Caffeine Concentration. A separate group of six rats was maintained on a restricted diet as above and was continuously exposed to caffeine (3.0 mg/ml) added to their drinking water. Daily caffeine intake was monitored once per week. After 3 weeks, the rats were sacrificed at the time when the nicotine-discrimination study would typically be performed and blood samples were collected into 10-ml sterile tubes containing EDTA as an anticoagulant. Tubes were centrifuged at 3500 rpm/min for 15 min to separate plasma from blood cells. Plasma samples were then transferred to transport tubes. Measurements of plasma caffeine concentration were commercially performed at Labstat Incorporated (Kitchener, Ontario, Canada) according to the HPLC method described in detail by Muir et al. (1980).

Data Presentation and Statistical Analysis. The percentage of nicotine-appropriate responses during each training or test session was obtained by dividing the number of responses on the nicotine-appropriate lever by the total number of responses on both levers during a session. The response rate (expressed as responses per second) during each session was calculated by dividing the total number of responses on both levers during a session by total session length (in seconds). Average values (± S.E.M.) for individual rats in each of the four groups were calculated. The percentage of nicotine-appropriate responses was considered as a measure of discrimination performance. The average response rate provided a second measure of the behavioral effects of treatment, a measure that was independent of the distribution of responses between the two levers. Additionally, daily fluid intake in milliliters per kilogram was calculated in water- and caffeine-drinking rats based on measured individual body weights and intakes of fluid. The daily fluid intakes of known caffeine concentration were then used to estimate intakes of caffeine in individual rats (in milligrams per kilogram per day) throughout the study. Daily caffeine intake and plasma caffeine concentration were expressed as mean ± S.E.M.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

Acquisition of Nicotine Discrimination. All 24 rats met the criteria for stimulus control (Fig. 1). There were, however, significant differences among the groups in the number of training sessions necessary before rats met the criteria for stimulus control (H₃= 11.655; p = .009). Water- and caffeine-drinking rats trained to discriminate 0.4 mg/kg nicotine from saline acquired the task within a comparable number of training sessions (p >.05) ranging from 28 to 43 (mean ± S.E.M.: 37.2 ± 2.3) and from 29 to 56 (mean ± S.E.M.: 43.0 ± 4.3), respectively. A significantly longer period of training was required for rats that were trained with the lower 0.1 mg/kg dose of nicotine (p <.05 versus rats trained with the 0.4 mg/kg nicotine dose). At the 0.1 mg/kg training dose of nicotine, the number of training sessions required for water- and caffeine-drinking rats to meet the criteria of stimulus control ranged from 38 to 94 (mean ± S.E.M.: 60.3 ± 8.0) and from 39 to 115 (mean ± S.E.M.: 85.5 ± 12.0), respectively (Fig. 1). There was a trend for caffeine-drinking rats to show a slower rate of acquisition of discriminative-stimulus control with the 0.1 mg/kg training dose of nicotine (Fig. 1), but this did not reach statistical significance (p >.05). Caffeine exposure did not effect rates of responding. At the end of acquisition training, response rates after 0.4 mg/kg of nicotine or saline in water-drinking rats (mean ± S.E.M.: 2.01 ± 0.22 or 1.57 ± 0.10 responses/s, respectively) were not significantly different (p > .05) from those after 0.4 mg/kg of nicotine or saline in caffeine-drinking rats, (1.89 ± 0.28 or 1.48 ± 0.09 responses/s, respectively). Similarly, response rates after 0.1 mg/kg of nicotine or saline in water-drinking rats (mean ± S.E.M.: 2.19 ± 0.28 or 1.88 ± 0.20 responses/s, respectively) were not significantly different (p >.05) from those after 0.1 mg/kg of nicotine or saline in caffeine-drinking rats, (1.82 ± 0.28 or 1.67 ± 0.14 responses/s, respectively).

View larger version (20K): [in this window] [in a new window]   Fig. 1.   Acquisition of nicotine discrimination. Open symbols represent water-drinking rats, solid symbols represent caffeine-drinking rats. Circles represent groups of water- and caffeine-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Triangles represent groups trained to discriminate 0.1 mg/kg of nicotine from saline. Each group consisted of six rats. Top, each symbol represents cumulative percentage of rats that met criteria for stimulus control (y-axis) over successive training sessions with nicotine or saline (x-axis) in water- and caffeine-drinking groups. Bottom, each symbol represents the number of sessions necessary for an individual rat to meet the criteria for stimulus control in water- and caffeine-drinking rats trained to discriminate 0.1 or 0.4 mg/kg of nicotine from saline. Symbols with error bars represent mean number of sessions (±S.E.M.) in each group. See Materials and Methods for the criteria for stimulus control.

Dose-Response Tests with Nicotine and Blockade of the Nicotine Cue by Mecamylamine in Water- and Caffeine-Drinking Rats. The percentage of nicotine-appropriate lever-press responses increased as the dose of nicotine increased in both groups, regardless of the training dose of nicotine (Fig. 2; Table 1). In both water- and caffeine-drinking rats trained with the 0.4-mg/kg dose of nicotine, the 4-fold lower dose of nicotine (0.1 mg/kg) engendered nicotine-appropriate responding in all rats, whereas lower 0.05- and 0.025-mg/kg doses of nicotine yielded either partial or no generalization. In contrast to the rats trained with 0.4 mg/kg of nicotine, rats trained with 0.1 mg/kg of nicotine showed only partial or no generalization when nicotine dose was reduced 2- or 4-fold below the training dose. There were no statistical differences in the potency of nicotine as a discriminative stimulus between water- and caffeine-drinking rats regardless of training dose (Tables 1 and 2; Fig. 2). A nicotine dose of 0.8 mg/kg markedly and significantly (p <.05) decreased response rates but 0.4 mg/kg and lower doses of nicotine had little effect on response rates of water- or caffeine-drinking rats in rats trained with either 0.4 or 0.1 mg/kg of nicotine (p >.05). There were no significant differences in effects on response rates of graded doses of nicotine between water- and caffeine-drinking rats trained with either 0.4 mg/kg or 0.1 mg/kg of nicotine (p >.05; Table 1).

View larger version (31K): [in this window] [in a new window]   Fig. 2.   Dose-response functions for the discriminative stimulus effects of nicotine and caffeine. Circles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Triangles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.1 mg/kg of nicotine from saline. Top, mean percentage of nicotine-appropriate responses (±S.E.M.; n = 5-6 rats) after injections with increasing doses of nicotine (s.c.; 10 min before test), caffeine (i.p.; 15 min before test), or control vehicle. Control points (vehicle instead of drug) were included to show the degree of stimulus control produced by vehicle given under test conditions (these points often overlap). Caffeine was tested only in the groups of rats trained to discriminate 0.4 mg/kg of nicotine from saline. Horizontal lines at 20% and 80% separate arrays of nicotine-appropriate responses, considered as no generalization (0-19%), partial generalization (20-79%) and full generalization (80-100%). Doses shown on the abscissa are in mg/kg, log scale. Bottom, mean percentage of change (±S.E.M.) from the individual baseline rate of responding during vehicle control after different doses of nicotine or caffeine. The dashed line at 0% denotes no change from vehicle-control response rates. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). See Tables 1 to 4 for the outcome of between-group comparisons and for ED50 values calculated, where appropriate, from these dose-response functions.

View larger version (35K): [in this window] [in a new window]   Fig. 3.   Results of antagonism tests with mecamylamine and CGS 10746B in water- and caffeine- drinking rats trained to discriminate nicotine from saline. Circles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Triangles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.1 mg/kg of nicotine from saline. Mecamylamine was tested in water- and caffeine-drinking rats trained to discriminate 0.1 or 0.4 mg/kg of nicotine from saline. CGS 10746B was tested only in the groups of rats trained to discriminate 0.4 mg/kg of nicotine from saline. Top, mean percentage of nicotine-appropriate responses (±S.E.M.; n = 5-6 rats) after injections with increasing doses of mecamylamine (s.c., 10 min before nicotine or saline) or CGS 10746B (i.p., 20 min before nicotine or saline). Doses shown on the abscissa are in mg/kg, log scale. Mecamylamine and CGS 10746B engendered only vehicle-appropriate responses when given before saline instead of nicotine (points labeled mec-1.0 + sal, mec-0.3 + sal, and CGS-30 + sal on abscissa; these points often overlap). Nicotine, when administered with a vehicle instead of mecamylamine or CGS 10746B, engendered nicotine-appropriate responses in all rats (points labeled with 0). Bottom, mean percentage of change (±S.E.M.) from the individual baseline rates of responding after different doses of mecamylamine or CGS 10746B. The individual baseline level of responding was recorded during a test session with appropriate vehicles administered instead of either nicotine or an antagonist. The dashed line at 0% denotes no change from the individual baseline rate of responding. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). X symbols represent performance after different doses of mecamylamine or CGS 10746B + nicotine that was significantly (p <.05) different from performance after mecamylamine vehicle or CGS 10746B vehicle + nicotine.

Tests for Generalization to Caffeine, Amphetamine Cocaine, and GBR-12909. In rats trained to discriminate 0.4 mg/kg of nicotine from saline, caffeine (1.0-56 mg/kg) failed to engender nicotine-appropriate responding in water-drinking rats or in caffeine-drinking rats (Fig. 2; Table 3). The maximum percentage of nicotine-appropriate responses was 35.1% (S.E.M., ± 20.5) after 56 mg/kg of caffeine in water-drinking rats and it did not reach the assigned level of statistical significance (p >.05 versus vehicle). In water-drinking rats, caffeine produced dose-dependent and biphasic changes in rates of responding (Table 3). Rates of responding increased after lower doses of caffeine (1.0 and 3.0 mg/kg) and decreased significantly after higher doses of caffeine (30 and 56 mg/kg). In contrast, in caffeine-drinking rats, there were no increases in rates of responding after lower doses of caffeine, but 30 to 56 mg/kg of caffeine did decrease response rates. There was a statistically significant interaction between two factors (water/caffeine drinking and dose of caffeine; F_4,40= 2.643, p = .048), indicative of a trend in caffeine-drinking rats to show tolerance to the rate increasing effects of lower doses of caffeine (1.0 and 3.0 mg/kg) (Fig. 2). Higher doses of caffeine (10-56 mg/kg) produced dose-dependent decreases in rates of responding with comparable (p >.05) potency and efficacy in water- and caffeine-drinking rats (Fig. 2, Tables 3 and 4), indicative of the lack of tolerance to the rate-decreasing effects of caffeine in rats chronically exposed to caffeine.

View larger version (30K): [in this window] [in a new window]   Fig. 4.   Dose-response functions for the discriminative stimulus generalization of amphetamine to the nicotine cue in water- and caffeine-drinking rats. Circles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Triangles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.1 mg/kg of nicotine from saline. Top, mean percentage of nicotine-appropriate responses (±S.E.M.; n = 5-6 rats) after injections with increasing doses of amphetamine or control vehicle (i.p.; 10 min before test). Bottom, mean percentage of change (±S.E.M.) from the individual baseline rates of responding after different doses of amphetamine. The individual baseline level of responding was recorded during a test session with an appropriate vehicle administered instead of amphetamine. The dashed line at 0% denotes no change from the individual baseline rate of responding. Doses shown on the abscissa are in mg/kg, log scale. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). See Fig. 2 for other details and Tables 3 and 4 for the outcome of between-group comparisons and for ED50 values calculated, where appropriate, from these dose-response functions.

View larger version (39K): [in this window] [in a new window]   Fig. 5.   Dose-response functions for the stimulus generalization of cocaine and GBR-12909 in water- and caffeine-drinking rats. Circles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Triangles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.1 mg/kg of nicotine from saline. Top, mean percentage of nicotine-appropriate responses (±S.E.M.; n = 5-6 rats) after injections with increasing doses of cocaine, GBR-12909, or control vehicle (i.p.; 10 min and 15 min before test). Bottom, mean percentage of change (±S.E.M.) from the individual baseline rates of responding (responses per second) after different doses of the drugs. The individual baseline level of responding was recorded during a test session with appropriate vehicles administered instead of either cocaine or GBR-12909. The dashed line at 0% denotes no change from the individual baseline rate of responding. Doses shown on the abscissa are in mg/kg, log scale. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). See Fig. 2 for other details and Tables 3 and 4 for the outcome of between-group comparisons and for ED50 values calculated, where appropriate, from these dose-response functions.

Tests for Generalization to Nonselective and Selective Dopaminergic Agents. The nonselective D1/D2 dopamine receptor agonist, apomorphine, significantly and dose-dependently generalized to the nicotine cue in water-drinking groups, with a maximal effect of 66.6% (S.E.M., ± 21.1) at 0.17 mg/kg and 63.9% (S.E.M., ± 18.0) at 0.3 mg/kg in rats trained to discriminate saline from 0.4 mg/kg and 0.1 mg/kg of nicotine, respectively (Fig. 6; Tables 4 and 5). Apomorphine, in contrast, failed to generalize to the nicotine cue in caffeine-drinking rats, regardless of the training dose of nicotine (p >.05 versus vehicle). Apomorphine also significantly and dose-dependently decreased rates of responding (Fig. 6). The rate-decreasing potency and efficacy of apomorphine were comparable (p >.05) in water- and caffeine-drinking rats, regardless of the training dose of nicotine (Tables 4 and 5; Fig. 6).

View larger version (36K): [in this window] [in a new window]   Fig. 6.   Dose-response functions for the stimulus generalization of apomorphine and PD 128,907 in water- and caffeine-drinking rats. Circles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Triangles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.1 mg/kg of nicotine from saline. Top, mean percentage of nicotine-appropriate responses (±S.E.M.; n = 5-6 rats) after injections with increasing doses of apomorphine, PD 128,907, or control vehicle (i.p.; 10 min and 15 min before test). Bottom, mean percentage of change (±S.E.M.) from the individual baseline rates of responding (responses per second) after different doses of apomorphine or PD 128,907. The individual baseline rate of responding was recorded during a test session with appropriate vehicles administered instead of either apomorphine or PD 128,907. The dashed line at 0% denotes no change from the individual baseline rate of responding. Doses shown on the abscissa are in mg/kg, log scale. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). See Fig. 2 for other details and Tables 4 and 5 for the outcome of between-group comparisons and for ED50 values calculated, where appropriate, from these dose-response functions.

View larger version (36K): [in this window] [in a new window]   Fig. 7.   Dose-response functions for the stimulus generalization of SKF-82958 and NPA in water- and caffeine-drinking rats. Circles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Triangles represent water ()- and caffeine ()-drinking rats trained to discriminate 0.1 mg/kg of nicotine from saline. Top, mean percentage of nicotine-appropriate responses (±S.E.M.; n = 5-6 rats) after injections with increasing doses of SKF-82958, NPA, or control vehicle (i.p.; 10 min before test). Bottom, mean percentage of change (±S.E.M.) from the individual baseline rate of responding (responses per second) after different doses of SKF-82958 or NPA. The individual baseline rate of responding was recorded during a test session with appropriate vehicles administered instead of SKF-82958 or NPA. The dashed line at 0% denotes no change from the individual baseline rate of responding. Doses shown on the abscissa are in mg/kg, log scale. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). See Fig. 2 for other details and Tables 4 and 5 for the outcome of between-group comparisons and for ED50 values calculated, where appropriate, from these dose-response functions.

Antagonism of the Nicotine Cue with the Dopamine-Release Inhibitor CGS 10746B. The dopamine-release inhibitor, CGS10746B, when administered 10 min before the training dose of 0.4 mg/kg of nicotine, dose-dependently, but not completely, reduced the discriminative effects of nicotine in water-drinking rats but not in caffeine-drinking rats (Fig. 3; Table 4). The most effective doses of CGS10746B appeared to be 10 and 17 mg/kg (reduction of the percentage of nicotine-appropriate responses from 100% to 38.8% (S.E.M., ± 21.2) and 47.7% (± 18.3), respectively, p <.05 versus 0.4 mg/kg of nicotine alone. These doses of CGS 10746B also significantly decreased the rate of responding. A higher dose of CGS 10746B (30 mg/kg) almost completely suppressed responding. In contrast to the different effects of CGS1076B upon the discriminative effects of nicotine in water- and caffeine-drinking rats, CGS 10746B dose-dependently and with a comparable (p >.05) efficacy and potency reduced rates of responding in water- and caffeine-drinking rats (Table 4).

Re-evaluation of the Dose-Response Curves of the Discriminative-Stimulus Effects of Nicotine. Dose-response functions for the discriminative-stimulus effects of nicotine were re-evaluated in each group after completion of the above-mentioned tests. In each group, nicotine again produced dose-dependent increases in the percentage of nicotine-appropriate responding with a comparable (p >.05) potency in water- and caffeine-drinking rats, regardless of the training dose of nicotine (Fig. 8; Tables 1 and 2). Likewise, the discriminative-stimulus effects of nicotine did not change significantly over time (Fig. 8). This was further confirmed by comparable ED₅₀ values of nicotine (Table 2). Similarly, the effects of nicotine on rates of responding did not differ between water-and caffeine-drinking rats, and the effects of nicotine on rates of responding did not change over the time (p >.05) (Fig. 8; Table 1 and 2).

View larger version (37K): [in this window] [in a new window]   Fig. 8.   Re-evaluation of the dose-response functions for the discriminative-stimulus effects of nicotine in water- and caffeine-drinking rats. Open and solid symbols represent water- and caffeine-drinking rats, respectively. Circles and triangles represent dose-response curves evaluated at the beginning of the study (re-plotted from Fig. 2 for comparison); squares represent dose-response curves re-evaluated in the same groups. Top, mean percentage of nicotine-appropriate responses (± S.E.M.; n = 5-6 rats) after injections with increasing doses of nicotine or saline (s.c.; 10 min before test). Bottom, mean percentage of change (±S.E.M.) from the individual baseline rate of responding (responses per second) after different doses of nicotine. The individual baseline rate of responding was recorded during a test session with saline administered instead of nicotine. The dashed line at 0% denotes no change from the individual baseline rate of responding. Doses shown on the abscissa are in mg/kg, log scale. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). See Fig. 2 for other details and Tables 1 and 2 for the outcome of between-group comparisons and for ED50 values calculated, where appropriate, from these dose-response functions.

Generalization of Amphetamine to the Nicotine Cue in Rats When the Water- and Caffeine-Drinking Conditions Were Reversed. In rats trained to discriminate 0.4 mg/kg of nicotine from saline, caffeine solution (3 mg/ml) was substituted for water solution in water-drinking rats and caffeine solution was replaced with water solution in caffeine-drinking rats. Rats were then allowed 3 weeks to habituate to the new drinking solutions, during which time they were kept in their home cages with no training. After 3 weeks, the ability of amphetamine (10 min before testing, i.p.) to generalize to the 0.4-mg/kg nicotine cue was re-evaluated (Fig. 9; Table 6). The water-drinking group of rats, in which amphetamine had previously fully generalized to the nicotine cue, no longer showed generalization of amphetamine to the nicotine cue after 3 or more weeks of caffeine exposure. Surprisingly, the caffeine-drinking group of rats, in which amphetamine had previously failed to generalize to the nicotine cue, continued to show no generalization to the nicotine cue with amphetamine after 3 or more weeks maintenance on water.

View larger version (27K): [in this window] [in a new window]   Fig. 9.   Dose-response functions for the stimulus generalization of amphetamine re-evaluated in water- and caffeine-drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline. Water and caffeine solutions were exchanged, so that water-drinking rats ( symbols) were exposed to caffeine solution (), whereas caffeine-drinking rats () were maintained on tap water since then (). Open () and solid () symbols representing, respectively, water- and caffeine-drinking rats are re-plotted from Fig. 4 for comparison. Squares and diamonds represent groups of animals after their solutions were changed. Each plot shows pairs of dose-response function evaluated in the same subjects (before and after; n = 5-6 per data point). Top, mean percentage of nicotine-appropriate responses (±S.E.M.) after injections with increasing doses of amphetamine or control vehicle (s.c.; 10 min before test). Doses shown on the abscissa are in mg/kg, log scale. Bottom, mean percentage of change (±S.E.M.) from the individual baseline rate of responding (responses per second) after different doses of amphetamine. The individual rate of responding was recorded during a test session with vehicle administered instead of amphetamine. The dashed line at 0% denotes no change from the individual baseline rate of responding. Asterisks represent performance significantly (p <.05) different from vehicle (Dunnett's test after one-way repeated measures ANOVA). See Fig. 2 for other details and Table 6 for the outcome of between-group comparisons and for ED50 values calculated, where appropriate, from these dose-response functions.

Absolute Values of Rates of Responding during the Study. Absolute values of rates of responding after administration of the appropriate vehicle under the testing condition were grouped (Fig. 10) and analyzed for changes in the baseline levels that might result from repeated exposure to different compounds or chronic caffeine exposure. One-way repeated measures ANOVA revealed a stable baseline level of responding throughout the study in water- (F_12,58 = 1.649, p = .103) and caffeine- (F_12,58 = 0.525, p = .888) drinking rats trained to discriminate 0.4 mg/kg of nicotine from saline and in water- (F_9,45 = 1.008, p = .449) and caffeine- (F_9,45 = 1.750, p = .105) drinking rats trained to discriminate 0.1 mg/kg of nicotine from saline. There were also no significant differences between water- and caffeine-drinking groups trained with 0.4 mg/kg (F_1,101 = 0.259, p = .622) or 0.1 mg/kg of nicotine (F_1,87 = 4.677, p = .056) according to two-way repeated measures ANOVA. In the groups trained with 0.1 mg/kg of nicotine, however, there was a tendency for water-drinking rats to show higher levels of baseline responding than caffeine-drinking rats.

View larger version (47K): [in this window] [in a new window]   Fig. 10.   Top and middle plots show untransformed mean values (±S.E.M.) of the baseline rates of responding in water- (open symbols) and caffeine- (solid symbols) drinking rats trained to discriminate 0.4 of mg/kg nicotine (top) or 0.1 mg/kg of nicotine (middle) from saline (n = 5-6 rats per group) during all test sessions with the different drugs as indicated in the legend. The average response rate during a session (expressed as responses per second) in an individual rat was calculated by dividing the total number of responses emitted by a rat on both levers by the total session length in seconds (900 s). These rates of responding were used as baseline levels of responding to calculate mean percentage of changes from individual level of responding produced by the respective drugs (Figs. 2-9). Bottom, calculated average intake (±S.E.M., n = 5-6 per data point) of caffeine (in mg/kg/day) during successive weeks in rats trained to discriminate 0.4 mg/kg of nicotine () or 0.1 mg/kg of nicotine () from saline. The shaded horizontal bars represent the number of weeks necessary for all rats from groups trained with either 0.4 mg/kg or 0.1 mg/kg of nicotine to meet the criteria of reliable stimulus control (see Fig. 1), whereas generalization and antagonism tests were performed during the remaining weeks (see Figs. 2-9).

Daily Intake and Plasma Concentration of Caffeine in Caffeine-Drinking Rats. The bottom plot in Fig. 10 shows the daily intake of caffeine The daily caffeine intake ranged from 93.9 ± 15.2 to 199.2 ± 17.1 mg/kg in the group of rats trained to discriminate 0.4 mg/kg of nicotine from saline, and from 86.1 ± 9.1 to 187.9 ± 8.0 mg/kg in the group of rats trained to discriminate 0.1 mg/kg of nicotine from saline, with average values from 76 measurements being 138.9 ± 24.5 mg/kg/day and 131.0 ± 23.3 mg/kg/day of caffeine in these groups. Overall, throughout the study (over 11/2 years), daily caffeine intakes in these two groups were indistinguishable during acquisition training and drug testing. Consumption of caffeinated water, however, remained from 10 to 15% below that of tap water throughout the study (data not shown). The latter had no effect on food consumption, body weights, or baseline performance (Fig. 10) of rats throughout the study.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

In the present study, chronic caffeine exposure during acquisition of a nicotine discrimination by rats changed the qualitative nature of the nicotine discrimination without affecting the rate at which the discrimination was acquired. The effect of chronic exposure to caffeine on the acquired nicotine cue in the present study appeared to be selective to its dopaminergic component, since a number of dopaminergic compounds, including amphetamine, cocaine, GBR-12909, apomorphine, and SKF-82958, failed to generalize to the nicotine cue in caffeine-drinking rats, whereas there was a complete or partial generalization with these compounds in water-drinking rats. However, chronic caffeine exposure did not appear to change the nicotinic component of the nicotine cue, as there were no differences between caffeine- and water-drinking rats in the nicotine dose-response functions nor in the ability of the nicotinic-receptor blocker mecamylamine to block the nicotine discriminative cue.

Rates of acquisition of nicotine discrimination for both lower and higher doses of nicotine in the present study with rats were similar to those reported in the literature (Chance et al., 1977; Stolerman et al., 1984; Rosecrans, 1989). As with Shoaib et al. (1997), there was no evidence for the development of either tolerance or sensitization to the discriminative stimulus effects of nicotine over time as a result of repeated treatment with nicotine and with various other compounds in the generalization and antagonism tests (Fig. 8). For example, the effects of graded doses of nicotine on rates of responding at the end of the study were comparable to those at the beginning of the study. Furthermore, the present findings from the generalization and antagonism tests generally resembled previous findings. Specifically, nicotine discrimination has been reported to be dose-related, with ED₅₀ values typically ranging from 0.04 to 0.1 mg/kg depending on the training dose and conditions (Stolerman, 1988; Rosecrans, 1989; Schechter and Meehan, 1992; Shoaib et al., 1997). In the present study, the ED₅₀ values of nicotine ranged from 0.044 to 0.088 mg/kg. The noncompetitive nicotinic-receptor antagonist mecamylamine dose-dependently blocked the discriminative stimulus effects of nicotine in the present study (Fig. 3) with comparable potency and efficacy to those found in the earlier studies (Romano et al., 1981; Stolerman et al., 1983, 1984). The present findings with partial generalization of amphetamine, cocaine, and the nonselective dopamine receptor agonist apomorphine to the nicotine cue, as well as the failure of caffeine to generalize to the nicotine cue (Figs. 2, 4, 5, and 6), have also been previously reported (Chance et al., 1977; Stolerman et al., 1984; Rosecrans, 1989). Finally, the dopamine-release inhibitor CGS 10746B has previously been shown to attenuate a nicotine discrimination in rats (Schechter and Meehan, 1992). In the present study, the blocking effect of CGS 10746B was also incomplete and its behavioral effects were characterized by a small separation between doses attenuating the discriminative-stimulus effect of nicotine and those producing a marked reduction in rates of responding.

In a previous study with Long-Evans rats trained to discriminate nicotine from saline, 5.0- and 30-mg/kg doses of GBR-12909 failed to generalize to the nicotine cue (Corrigall and Coen, 1994); the higher dose produced complete suppression of responding in four of six rats. In the present study, however, GBR-12909 produced full generalization in water-drinking Sprague-Dawley rats to both the 0.1- and 0.4-mg/kg nicotine cues at doses of 10 and 13 mg/kg (intermediate doses of GBR-12909 not studied by Corrigall and Coen, 1994) and partial generalization at 5.6 mg/kg. Higher doses of GBR-12909, as with Corrigall and Coen (1994), suppressed responding. Given that there is a symmetrical generalization between GBR-12909 and cocaine in rats and monkeys (Melia and Spealman, 1991; Witkin et al., 1991; Spealman, 1993), likely due to overlapping pharmacological mechanisms of action (Feldman et al., 1997), and that cocaine partially generalized to the nicotine cue (present study and Stolerman et al., 1984), partial generalization of GBR-12909 to the nicotine cue would have been expected.

The role of D1 and D2 dopamine receptors in the mediation of nicotine's discriminative stimulus effects has been studied by Stolerman and coworkers. The selective D1 dopamine-receptor agonist SKF 38393 partially generalized to the nicotine cue (Stolerman and Reavil, 1989). Moreover, the selective D1 dopamine antagonist SCH 23390 significantly attenuated nicotine discrimination, whereas two neuroleptics with selectivity for D2 dopamine receptors had no effect (Reavil and Stolerman, 1987). In the present study, the selective D1 dopamine-receptor agonist SKF-82958 generalized to the nicotine cue in water-drinking rats, whereas the selective D2 dopamine-receptor agonist NPA produced only saline-appropriate responses (Fig. 7), supporting these earlier findings indicating involvement of D1 but not D2 dopamine receptors in mediation of the discriminative-stimulus effects of nicotine in rodents.

It has recently been suggested that D3 dopamine autoreceptors may be involved in the pathogenesis of neuropsychiatric disorders such as schizophrenia and drug addiction, and the potential clinical use of selective D3 dopamine receptor agonists is now being explored (Caine and Koob, 1993; Acri et al., 1995; Lamas et al., 1996; Levant, 1997; Sanger et al., 1997; Witkin et al., 1998). Stimulation of D3 dopamine autoreceptors by selective compounds results in a dose-dependent inhibition of dopamine release in vivo and in vitro, and also has been implicated in blocking the reinforcing effects of amphetamine and cocaine (for review see Levant, 1997). Of importance for the present study, the discriminative stimulus effects of D3 dopamine-receptor agonists (e.g., 7-hydroxydipropylaminotetralin hydrobromide, PD 128,907) are similar to those of cocaine and the nonselective dopamine receptor agonist apomorphine in both rats and monkeys (Acri et al., 1995